Cargando…
Peritoneal carcinomatosis from ovarian cancer: chemosensitivity test and tissue markers as predictors of response to chemotherapy
BACKGROUND: Platinum-based regimens are the treatments of choice in ovarian cancer, which remains the leading cause of death from gynecological malignancies in the Western world. The aim of the present study was to compare the advantages and limits of a conventional chemosensitivity test with those...
Autores principales: | Arienti, Chiara, Tesei, Anna, Verdecchia, Giorgio Maria, Framarini, Massimo, Virzì, Salvatore, Grassi, Antonio, Scarpi, Emanuela, Turci, Livia, Silvestrini, Rosella, Amadori, Dino, Zoli, Wainer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141502/ https://www.ncbi.nlm.nih.gov/pubmed/21689426 http://dx.doi.org/10.1186/1479-5876-9-94 |
Ejemplares similares
-
DNA ploidy and S-phase fraction analysis in peritoneal carcinomatosis from ovarian cancer: correlation with clinical pathological factors and response to chemotherapy
por: Carloni, Silvia, et al.
Publicado: (2017) -
Peripheral Blood miR-328 Expression as a Potential Biomarker for the Early Diagnosis of NSCLC
por: Ulivi, Paola, et al.
Publicado: (2013) -
Predictive Role of Telomerase Activity in the Clinical Outcome of Patients with Benign Lesions of the Uterine Cervix or CIN
por: Bravaccini, Sara, et al.
Publicado: (2012) -
Low-dose taxotere enhances the ability of sorafenib to induce apoptosis in gastric cancer models
por: Tesei, Anna, et al.
Publicado: (2011) -
Zoledronic acid increases docetaxel cytotoxicity through pMEK and Mcl-1 inhibition in a hormone-sensitive prostate carcinoma cell line
por: Fabbri, Francesco, et al.
Publicado: (2008)